KLK3 and benign prostatic hyperplasia: It is known that biomarkers (such as cytokines, lipids or organ-specific biomarkers such as PSA (52–54)) change with age, as does the likelihood of developing age-related conditions such as prostate enlargement (55) or bladder cancer (56).